Filter posts

President Obama Talks Climate Change: “We need to act”

On the steps of Georgetown University Tuesday, President Obama announced his multi-step plan to fight …

MERS, Patents, and Material Transfer Agreements: What WHO Didn't Know

The outbreak of the Middle East Respiratory Syndrome (MERS-CoV), a SARS like virus has lead …

Myriad Supreme Court Decision: BIO’s Statement

Statement On U.S. Supreme Court Review Of Isolated DNA Patents Washington, D.C. (June 13, 2013) …

IP in Latin America: Growing Recognition of the Importance of IP to Innovation

The Inter-American Dialogue’s daily Latin America Advisor recently asked the question “How seriously do Latin …

Gene Patents, Angelina Jolie, and Reality

By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization  Angelina …

Canada Patent Utility: Former USPTO Director Interview at BIO Convention

David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and …

What OxyContin Tells Us About the Value of “Evergreening" and Patents

A few weeks ago, the  FDA announced that they would not allow generic versions of …

The Justness of Gene Patents

Most of the biotechnology world awaits the U.S. Supreme Court’s answer to the Question Presented, …

Governors Share Best Practices on Bringing Biotech Jobs to their States

With the state competition for biotech jobs in full force at the BIO International Convention, …

Legislative Hopes, Fears

Biotechnology advances are poised now more than ever to help policymakers achieve their goals of …